Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PreventiOn of DYSbioSis Complications With Autologous Fecal Microbiota Transplantation in acutE myEloid Leukemia Patients Undergoing Intensive Treatment (ODYSSEE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02928523
Recruitment Status : Completed
First Posted : October 10, 2016
Last Update Posted : June 25, 2018
Sponsor:
Information provided by (Responsible Party):
MaaT Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2017
Actual Study Completion Date : June 20, 2018